title: What can we learn from the three megatrials using anticoagulants in severe sepsis?
authors.affiliation: Department of Surgery, Juntendo Urayasu Hospital, Juntendo University School of Medicine, Chiba 279-0021, Japan. iba-jun@umin.ac.jp
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Iba
authors.forename: Akio
authors.initials: A
authors.lastname: Kidokoro
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D018805:Sepsis / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index
chemical_list: D000925:Anticoagulants; D006493:Heparin